Frizzled-4
Homo sapiens
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein heterocomplex Heteromer Protein × 3 PDB declaration: trimeric(3) Consistent with protein copy count | Chain A; UniProt 1–537 Chain B; UniProt 1–537 | Not recorded | Segment polarity protein dishevelled homolog DVL-2 × 1 (O14641) Y01 CHOLESTEROL HEMISUCCINATE × 10 | ELECTRON MICROSCOPY cryo-EM buffer:pH 7.5 cryo-EM vitrification conditions:Cryogen ETHANE | Resolution 3.53 Å |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 8WM9 | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 5BPB Crystal structure of the cysteine-rich domain of human Frizzled 4 - Crystal Form I Deposited 2015-05-27 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
42–179(138 aa)
Fragment:UNP residues 42-179
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;294 K;1.6 M tri-sodium citrate, pH 6.5
|
Resolution 2.20 Å R-free 0.223 |
| 5BPB Crystal structure of the cysteine-rich domain of human Frizzled 4 - Crystal Form I Deposited 2015-05-27 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
42–179(138 aa)
Fragment:UNP residues 42-179
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;294 K;1.6 M tri-sodium citrate, pH 6.5
|
Resolution 2.20 Å R-free 0.223 |
| 5BPB Crystal structure of the cysteine-rich domain of human Frizzled 4 - Crystal Form I Deposited 2015-05-27 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain D
42–179(138 aa)
Fragment:UNP residues 42-179
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;294 K;1.6 M tri-sodium citrate, pH 6.5
|
Resolution 2.20 Å R-free 0.223 |
| 5BPB Crystal structure of the cysteine-rich domain of human Frizzled 4 - Crystal Form I Deposited 2015-05-27 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 4 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain C
42–179(138 aa)
Fragment:UNP residues 42-179
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 7.5;294 K;1.6 M tri-sodium citrate, pH 6.5
|
Resolution 2.20 Å R-free 0.223 |
| 5BPQ Crystal structure of the cysteine-rich domain of human Frizzled 4 - Crystal Form II Deposited 2015-05-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
42–179(138 aa)
Fragment:cysteine-rich domain, UNP residues 42-179
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 CL CHLORIDE ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;294 K;0.1 M HEPES, pH 7.5, 0.1 M NaCl, 1.6 M ammonium sulfate
|
Resolution 2.40 Å R-free 0.243 |
| 5BPQ Crystal structure of the cysteine-rich domain of human Frizzled 4 - Crystal Form II Deposited 2015-05-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
42–179(138 aa)
Fragment:cysteine-rich domain, UNP residues 42-179
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;294 K;0.1 M HEPES, pH 7.5, 0.1 M NaCl, 1.6 M ammonium sulfate
|
Resolution 2.40 Å R-free 0.243 |
| 5BPQ Crystal structure of the cysteine-rich domain of human Frizzled 4 - Crystal Form II Deposited 2015-05-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 3 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain C
42–179(138 aa)
Fragment:cysteine-rich domain, UNP residues 42-179
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;294 K;0.1 M HEPES, pH 7.5, 0.1 M NaCl, 1.6 M ammonium sulfate
|
Resolution 2.40 Å R-free 0.243 |
| 5BPQ Crystal structure of the cysteine-rich domain of human Frizzled 4 - Crystal Form II Deposited 2015-05-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 4 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain D
42–179(138 aa)
Fragment:cysteine-rich domain, UNP residues 42-179
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;294 K;0.1 M HEPES, pH 7.5, 0.1 M NaCl, 1.6 M ammonium sulfate
|
Resolution 2.40 Å R-free 0.243 |
| 5BQC Crystal structure of Norrin in complex with the cysteine-rich domain of Frizzled 4 and sucrose octasulfate Deposited 2015-05-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain B
42–179(138 aa)
Fragment:residues 42-179
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;294 K;0.1 M Tris, pH 8.0, 0.15 M NaCl, 8% PEG8000
|
Resolution 3.00 Å R-free 0.268 |
| 5BQE Crystal structure of Norrin in complex with the cysteine-rich domain of Frizzled 4 -Methylated form Deposited 2015-05-28 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain C
42–179(138 aa)
Fragment:residues 42-179
|
Non-standard monomer:Yes (specific site not provided by mmCIF) | PG0 2-(2-METHOXYETHOXY)ETHANOL × 4 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 CL CHLORIDE ION × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;294 K;0.1 M Bicine, pH 9.0, 10% PEG6000
|
Resolution 2.30 Å R-free 0.221 |
| 5CL1 Complex structure of Norrin with human Frizzled 4 Deposited 2015-07-16 | Different construct Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain C
38–160(123 aa)
Fragment:UNP residues 38-160
Chain D
38–160(123 aa)
Fragment:UNP residues 38-160
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;298 K;200 mM ammonium sulfate, 100 mM sodium cacodylate trihydrate (pH 6.5), 15% w/v polyethylene glycol 8,000
|
Resolution 3.80 Å R-free 0.310 |
| 5CM4 Crystal structure of human Frizzled 4 Cysteine-Rich Domain (CRD) Deposited 2015-07-16 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Other combination Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
40–164(125 aa)
Fragment:UNP residues 40-164
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;293 K;1.8 M ammonium sulfate, 0.1 M tri-Na citrate pH 5.6 and 0.2 M Na/K tartrate
|
Resolution 2.40 Å R-free 0.255 |
| 5CM4 Crystal structure of human Frizzled 4 Cysteine-Rich Domain (CRD) Deposited 2015-07-16 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
40–164(125 aa)
Fragment:UNP residues 40-164
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;293 K;1.8 M ammonium sulfate, 0.1 M tri-Na citrate pH 5.6 and 0.2 M Na/K tartrate
|
Resolution 2.40 Å R-free 0.255 |
| 5UWG The crystal structure of Fz4-CRD in complex with palmitoleic acid Deposited 2017-02-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
40–164(125 aa)
Fragment:Cysteine Rich Domain (UNP residues 40-164)
|
Not recorded | PAM PALMITOLEIC ACID × 1 NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 3.5;293 K;0.1 M citric acid pH 3.5, 28% w/v polyethylene glycol 8,000
|
Resolution 2.56 Å R-free 0.267 |
| 5UWG The crystal structure of Fz4-CRD in complex with palmitoleic acid Deposited 2017-02-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 2 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
40–164(125 aa)
Fragment:Cysteine Rich Domain (UNP residues 40-164)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;pH 3.5;293 K;0.1 M citric acid pH 3.5, 28% w/v polyethylene glycol 8,000
|
Resolution 2.56 Å R-free 0.267 |
| 6BD4 Crystal structure of human apo-Frizzled4 receptor Deposited 2017-10-21 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
178–419(242 aa)
Chain A
428–517(90 aa)
|
Mutation:M309L, C450I, C507F, S508Y Mutation:M309L, C450I, C507F, S508Y | ZN ZINC ION × 1 OLC (2R)-2,3-dihydroxypropyl (9Z)-octadec-9-enoate × 4 OLA OLEIC ACID × 5 SO4 SULFATE ION × 3 UNX UNKNOWN LIGAND × 4 |
X-RAY DIFFRACTION
X-ray crystallization conditions
LIPIDIC CUBIC PHASE;pH 6;293 K;100 mM sodium cacodylate trihydrate (pH 6.0), 80 mM Magnesium Sulfate, 30% PEG400, 1.5-2.5% v/v (+/-)-2-Methyl-2,4-pentanediol
|
Resolution 2.40 Å R-free 0.233 |
| 6NE1 Designed repeat protein in complex with Fz4 Deposited 2018-12-15 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental method Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
42–161(120 aa)
|
Not recorded | NAG 2-acetamido-2-deoxy-beta-D-glucopyranose × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;295 K;0.2 M ammonium chloride, pH 6.3 and 20% PEG3,350
|
Resolution 3.01 Å R-free 0.293 |
| 8WMA Fzd4/DEP complex (local refined) Deposited 2023-10-03 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
1–537(537 aa)
|
Not recorded | No recorded non-water small molecule |
ELECTRON MICROSCOPY
cryo-EM buffer
pH 7.5
cryo-EM vitrification conditions
Cryogen ETHANE
|
Resolution 3.47 Å |
10 other PDB entries and 18 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | FZD4_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 1–537; UniProt 1–537 Author chain B; PDBConstruct 1–537; UniProt 1–537 |